Back
Speaker illustration

Doctor Frederic Tremblay

Boston (United States of America)

Presentations

An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates

Event: ESC Congress 2024

Topic: Genetics, Epigenetics, ncRNA

Session: Epigenetic regulators and tools

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources